Cancer and the immune system share a complex relationship, where immune cells play dual roles in tumor progression and suppression. The immune system can detect and eliminate nascent tumor cells through immune surveillance, primarily driven by T cells, natural killer cells, and antigen-presenting cells. However, cancer often evades immune control through mechanisms such as immune checkpoint inhibition, regulatory T cell activation, and secretion of immunosuppressive factors.The advent of immunotherapy has revolutionized cancer treatment, employing strategies like immune checkpoint inhibitors, adoptive T cell therapy, and cancer vaccines. Despite significant successes, challenges remain, including immune resistance, treatment toxicity, and limited efficacy in certain cancers.Future directions emphasize personalized medicine, combination therapies, and the development of novel biomarkers to predict treatment response. Understanding tumor-immune interactions at molecular and cellular levels is key to overcoming existing challenges and harnessing immunity for more effective cancer therapies.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Dr. Dalia Medhat, Professor of Medical Biochemistry at the National Research Centre, Egypt, has over 15 years of experience in medical research and translational science. Her work spans cancer biology, stem cell research, nanomedicine, and the therapeutic potential of natural compounds in diabetes, neurodegenerative diseases, and liver health.
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
Anbieter: PBShop.store US, Wood Dale, IL, USA
PAP. Zustand: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Bestandsnummer des Verkäufers L0-9783639662092
Anzahl: Mehr als 20 verfügbar
Anbieter: PBShop.store UK, Fairford, GLOS, Vereinigtes Königreich
PAP. Zustand: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Bestandsnummer des Verkäufers L0-9783639662092
Anzahl: Mehr als 20 verfügbar
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
Zustand: New. In. Bestandsnummer des Verkäufers ria9783639662092_new
Anzahl: Mehr als 20 verfügbar
Anbieter: Books Puddle, New York, NY, USA
Zustand: New. Bestandsnummer des Verkäufers 26403783972
Anzahl: 4 verfügbar
Anbieter: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Deutschland
Taschenbuch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware 68 pp. Englisch. Bestandsnummer des Verkäufers 9783639662092
Anzahl: 2 verfügbar
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
Zustand: New. Print on Demand. Bestandsnummer des Verkäufers 409403131
Anzahl: 4 verfügbar
Anbieter: Biblios, Frankfurt am main, HESSE, Deutschland
Zustand: New. PRINT ON DEMAND. Bestandsnummer des Verkäufers 18403783982
Anzahl: 4 verfügbar
Anbieter: buchversandmimpf2000, Emtmannsberg, BAYE, Deutschland
Taschenbuch. Zustand: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Cancer and the immune system share a complex relationship, where immune cells play dual roles in tumor progression and suppression. The immune system can detect and eliminate nascent tumor cells through immune surveillance, primarily driven by T cells, natural killer cells, and antigen-presenting cells. However, cancer often evades immune control through mechanisms such as immune checkpoint inhibition, regulatory T cell activation, and secretion of immunosuppressive factors.The advent of immunotherapy has revolutionized cancer treatment, employing strategies like immune checkpoint inhibitors, adoptive T cell therapy, and cancer vaccines. Despite significant successes, challenges remain, including immune resistance, treatment toxicity, and limited efficacy in certain cancers.Future directions emphasize personalized medicine, combination therapies, and the development of novel biomarkers to predict treatment response. Understanding tumor-immune interactions at molecular and cellular levels is key to overcoming existing challenges and harnessing immunity for more effective cancer therapies.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 68 pp. Englisch. Bestandsnummer des Verkäufers 9783639662092
Anzahl: 1 verfügbar
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Taschenbuch. Zustand: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering. Bestandsnummer des Verkäufers 9783639662092
Anzahl: 1 verfügbar